Literature DB >> 11301131

Antibacterial vaccine design using genomics and proteomics.

G Grandi1.   

Abstract

After 200 years of practice, vaccinology has proved to be very effective in preventing infectious diseases. However, several human and animal pathogens exist for which vaccines have not yet been discovered. As for other fields of medical sciences, it is expected that vaccinology will greatly benefit from the emerging genomics technologies such as bioinformatics, proteomics and DNA microarrays. In this article the potential of these technologies applied to bacterial pathogens is analyzed, taking into account the few existing examples of their application in vaccine discovery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301131     DOI: 10.1016/s0167-7799(01)01600-6

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  25 in total

1.  Genomic approach for analysis of surface proteins in Chlamydia pneumoniae.

Authors:  Silvia Montigiani; Fabiana Falugi; Maria Scarselli; Oretta Finco; Roberto Petracca; Giuliano Galli; Massimo Mariani; Roberto Manetti; Mauro Agnusdei; Roberto Cevenini; Manuela Donati; Renzo Nogarotto; Nathalie Norais; Ignazio Garaguso; Sandra Nuti; Giulietta Saletti; Domenico Rosa; Giulio Ratti; Guido Grandi
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Immunoproteomic analysis to identify Shiga toxin-producing Escherichia coli outer membrane proteins expressed during human infection.

Authors:  David Montero; Paz Orellana; Daniela Gutiérrez; Daniela Araya; Juan Carlos Salazar; Valeria Prado; Angel Oñate; Felipe Del Canto; Roberto Vidal
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 3.  DNA microarrays--techniques and applications in microbial systems.

Authors:  T Majtán; G Bukovská; J Timko
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

4.  Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.

Authors:  Francesco Doro; Sabrina Liberatori; Manuel J Rodríguez-Ortega; Cira D Rinaudo; Roberto Rosini; Marirosa Mora; Maria Scarselli; Emrah Altindis; Romina D'Aurizio; Maria Stella; Immaculada Margarit; Domenico Maione; John L Telford; Nathalie Norais; Guido Grandi
Journal:  Mol Cell Proteomics       Date:  2009-04-28       Impact factor: 5.911

Review 5.  Secretome, surfome and immunome: emerging approaches for the discovery of new vaccine candidates against bacterial infections.

Authors:  Pratistha Dwivedi; Syed Imteyaz Alam; Rajesh Singh Tomar
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

6.  The unique structure of Haemophilus influenzae protein E reveals multiple binding sites for host factors.

Authors:  Birendra Singh; Tamim Al-Jubair; Matthias Mörgelin; Marjolein M Thunnissen; Kristian Riesbeck
Journal:  Infect Immun       Date:  2012-12-28       Impact factor: 3.441

7.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

8.  Elucidation of the outer membrane proteome of Salmonella enterica serovar Typhimurium utilising a lipid-based protein immobilization technique.

Authors:  Darren Chooneea; Roger Karlsson; Vesela Encheva; Cath Arnold; Hazel Appleton; Haroun Shah
Journal:  BMC Microbiol       Date:  2010-02-11       Impact factor: 3.605

9.  IMMUNOCAT-a data management system for epitope mapping studies.

Authors:  Jo L Chung; Jian Sun; John Sidney; Alessandro Sette; Bjoern Peters
Journal:  J Biomed Biotechnol       Date:  2010-05-17

10.  Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens.

Authors:  N Ariel; A Zvi; K S Makarova; T Chitlaru; E Elhanany; B Velan; S Cohen; A M Friedlander; A Shafferman
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.